➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKesson
Moodys
Colorcon
Medtronic
McKinsey

Last Updated: October 19, 2020

DrugPatentWatch Database Preview

VALGANCICLOVIR HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Valganciclovir Hydrochloride patents expire, and when can generic versions of Valganciclovir Hydrochloride launch?

Valganciclovir Hydrochloride is a drug marketed by Actavis Labs Fl Inc, Ajanta Pharma Ltd, Granules Pharms, Aurobindo Pharma Ltd, Cipla, Dr Reddys, Dr Reddys Labs Ltd, Endo Pharms Inc, and Hetero Labs Ltd V. and is included in ten NDAs.

The generic ingredient in VALGANCICLOVIR HYDROCHLORIDE is valganciclovir hydrochloride. There are seventeen drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the valganciclovir hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Valganciclovir Hydrochloride

A generic version of VALGANCICLOVIR HYDROCHLORIDE was approved as valganciclovir hydrochloride by DR REDDYS LABS LTD on November 4th, 2014.

  Start Trial

Drug patent expirations by year for VALGANCICLOVIR HYDROCHLORIDE
Recent Clinical Trials for VALGANCICLOVIR HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Barcelona Institute for Global HealthPhase 2/Phase 3
Stichting Katholieke UniversiteitPhase 2/Phase 3
Eduardo Mondlane UniversityPhase 2/Phase 3

See all VALGANCICLOVIR HYDROCHLORIDE clinical trials

Pharmacology for VALGANCICLOVIR HYDROCHLORIDE
Paragraph IV (Patent) Challenges for VALGANCICLOVIR HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
VALCYTE FOR SOLUTION;ORAL valganciclovir hydrochloride 022257 2011-03-21
VALCYTE TABLET;ORAL valganciclovir hydrochloride 021304 2005-12-27

US Patents and Regulatory Information for VALGANCICLOVIR HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride FOR SOLUTION;ORAL 205220-001 Jul 18, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride TABLET;ORAL 206876-001 Dec 12, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
Ajanta Pharma Ltd VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride TABLET;ORAL 212234-001 Dec 26, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Dr Reddys Labs Ltd VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride TABLET;ORAL 203511-001 Nov 4, 2014 AB RX No No   Start Trial   Start Trial   Start Trial
Ajanta Pharma Ltd VALGANCICLOVIR HYDROCHLORIDE valganciclovir hydrochloride FOR SOLUTION;ORAL 212890-001 Jan 13, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
AstraZeneca
Moodys
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.